Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-12-05
1996-08-13
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514185, 5142248, 514249, 514255, 514551, 514564, A61K 3842, A61K 31195, A61K 3122, A61K 31495
Patent
active
055456146
ABSTRACT:
A method for inhibiting or relaxing skeletal muscle contractions and for treating disease states resulting from or exacerbated by undesirable skeletal muscle contractions by administering a skeletal muscle relaxing amount of nitroxyl ion(NO.sup.-), nitrosonium ion(NO.sup.+), nitric oxide and nitric oxide adducts or providers. A process for stimulating, improving or enhancing muscle contraction in a mammal by treating the mammal with an effective amount of (i) a nitric oxide synthase inhibitor or (ii) a nitric oxide scavenger.
REFERENCES:
patent: 5028627 (1991-07-01), Kilbourn et al.
patent: 5039520 (1991-08-01), Hunter et al.
patent: 5266594 (1993-11-01), Dawson et al.
patent: 5296466 (1994-03-01), Kilbourn et al.
patent: 5358969 (1994-10-01), Williamson et al.
patent: 5449688 (1995-09-01), Wahl et al.
J. Pharmacology and Experimental Therapeutics, vol. 254, No. 3, issued 1990, Wolin et al, "Methylene Blue Inhibits Vasodilation . . . ", pp. 872-876.
Pediatric Research, vol. 35 (4 Part 2), issued Apr. 1994, Williams et al, "Induction And Characterization of Inducible . . . ", p. 61A, abstract No. 350.
Kobzik Lester
Stamler Jonathan
Duke Univ.
Harvard College
Herron Charles J.
Olstein Elliot M.
Russel Jeffrey E.
LandOfFree
Controlling nitrogen oxide concentrations to modulate skeletal m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlling nitrogen oxide concentrations to modulate skeletal m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlling nitrogen oxide concentrations to modulate skeletal m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1047927